Abstract
The μ-opioid receptor antagonist effects of naloxonazine on levorphanol-induced thermal antinociception and respiratory depression were examined in rhesus monkeys. Levorphanol (0.032-3.2 mg/kg) produced dose-dependent increases in tail-withdrawal latencies from 50°C water in a warm-water tail-withdrawal assay and dose-dependent decreases in ventilation in both air and 5% CO2 mixed in air. Naloxonazine (0.1-3.0 mg/kg) antagonized both the antinociceptive and ventilatory effects of levorphanol to a similar degree, and the antagonist effects of naloxonazine were greater after 1 h than after 24 h. Under all conditions, the antagonist effects of naloxonazine were fully surmountable. Schild analysis of the antagonist effects of naloxonazine after 1 h pretreatment in the antinociception assay yielded a pA2 value of 7.6 and a slope of -0.50; by comparison, quadazocine yielded a pA2 value of 7.5 and a slope of -1.05. These results suggest that naloxonazine acts as a potent and fully reversible μ-opioid receptor antagonist with a moderately long duration of action in rhesus monkeys. In addition, these results suggest that the antinociceptive and ventilatory effects of μ-opioid receptor agonists in rhesus monkeys are mediated by pharmacologically similar populations of μ opioid receptors.
Original language | English |
---|---|
Pages (from-to) | 31-36 |
Number of pages | 6 |
Journal | European Journal of Pharmacology |
Volume | 298 |
Issue number | 1 |
DOIs | |
State | Published - 29 Feb 1996 |
Keywords
- Antinociception
- Levorphanol
- Macaca mulatta
- Naloxonazine
- Opioid receptor
- Quadazocine
- Respiratory depression